Dr. Lisa Diller is co-principal investigator on the Crazy 8 team studying newborn screening for early childhood cancer predisposition syndromes.

She is the Vice Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute. She is also the Director of the Perini Family Survivors Center and the David B. Perini Jr. Quality of Life Clinic at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelor's degree from Harvard University and earned her medical degree from the University of California at San Diego. She was a resident at Boston Children's Hospital and did her subspecialty training at Dana-Farber/Boston Children's, where she has been on the faculty for over 20 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.